Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?

Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women, potentially due to ineffectiveness of screening tests for early detection. Patients typically present with advanced disease at diagnosis, whereas, up to 80% relapse and the estimated median progression-free s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Boussios, Stergios, Moschetta, Michele, Karihtala, Peeter, Samartzis, Eleftherios P., Sheriff, Matin, Pappas-Gogos, George, Ozturk, Mehmet Akif, Uccello, Mario, Karathanasi, Afroditi, Tringos, Michail, Rassy, Elie, Pavlidis, Nicholas
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Review Article on Ovarian Cancer: State of the Art and Perspectives of Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812175/
https://ncbi.nlm.nih.gov/pubmed/33490218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.03.156
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados